A submission to the U.S. Food and Drug Administration (FDA) seeking approval to market a generic version of a previously approved branded drug. This application relies on the safety and efficacy findings of the original drug.
Meet us at Tides Europe 2026, Stand No. 805, Nov 3-5, RAI Amsterdam, Netherlands Schedule a Meeting
Explore how Neuland supports API programs from pre-IND through commercial manufacturing.